Dexmedetomidine and Agitation After Nasal Surgery
Effectiveness of Single Bolus Versus Continuous Infusion of Dexmedetomidine in Mitigating Agitation in Adults Undergoing Nasal Surgery: a Prospective Randomized Trial
Fayoum University Hospital
50 participants
Mar 1, 2025
INTERVENTIONAL
Conditions
Summary
The main objective of study is to compare dexmedetomidine single bolus dose before extubation with continuous infusion as regards their efficacy in mitigating the incidence of emergence agitation in obese adults undergoing nasal surgery.
Eligibility
Inclusion Criteria3
- American Society of Anesthesiologist (ASA) Ⅰ or II
- Adults with body mass index (BMI) \< 30 Kg/m
- Underwent elective nasal surgery.
Exclusion Criteria6
- Significant comorbidity like hepatic, renal, or cardiac disease
- Auditory impairment
- Cognitive dysfunction
- Substance abuse
- Allergy to the studied medicines
- Planned intensive care admission after the surgery.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
An infusion given all through intraoperative time
Single dose given 15 minutes before end of surgery
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06867302